Compare BETR & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BETR | OPRX |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | 105 |
| Industry | Finance: Consumer Services | Business Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.6M | 167.1M |
| IPO Year | 2021 | 2008 |
| Metric | BETR | OPRX |
|---|---|---|
| Price | $15.27 | $7.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $24.00 | $11.90 |
| AVG Volume (30 Days) | ★ 849.4K | 200.4K |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.88 | ★ 124.55 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $164,872,000.00 | $109,429,000.00 |
| Revenue This Year | $13.39 | N/A |
| Revenue Next Year | $23.31 | $8.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 51.97 | 18.78 |
| 52 Week Low | $7.51 | $4.54 |
| 52 Week High | $55.75 | $15.59 |
| Indicator | BETR | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.92 | 37.22 |
| Support Level | $10.45 | $7.23 |
| Resistance Level | $31.07 | $8.30 |
| Average True Range (ATR) | 2.39 | 0.69 |
| MACD | -0.68 | -0.19 |
| Stochastic Oscillator | 3.48 | 38.21 |
Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.